{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:34:36Z","timestamp":1775608476697,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2U54NS059065"],"award-info":[{"award-number":["2U54NS059065"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011125","name":"School of Medicine and Dentistry, University of Rochester","doi-asserted-by":"publisher","award":["UL1 RR 024160 NCRR\/NIH"],"award-info":[{"award-number":["UL1 RR 024160 NCRR\/NIH"]}],"id":[{"id":"10.13039\/100011125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0601943"],"award-info":[{"award-number":["G0601943"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Episodic ataxia type 1 (EA1) is a rare autosomal potassium channelopathy, due to mutations in <jats:italic>KCNA1<\/jats:italic>. Patients have childhood onset of intermittent attacks of ataxia, dizziness or imbalance. In order to quantify the natural history of EA1, its effect on quality of life and in preparation for future clinical trials, we set up an international multi-centre study of EA1. We recruited thirty-three participants with EA1: twenty-three completed 1-year follow-up and eighteen completed 2-year follow-up. There was very little accumulation of disability or impairment over the course of the 2\u00a0years of the study. The outcome measures of ataxia (SARA and functional rating of ataxia) and the activities of daily living scale were largely stable over time. Self-reported health-related quality of life (SF-36) scores were lower across all domains than controls, in keeping with a chronic condition. Physical subdomain scores appeared to deteriorate over time, which seems to be driven by the female participants in the study. This is an interesting finding and warrants further study. Attacks of EA1 reported by participants in real time via an interactive voice response system showed that symptoms were not stereotyped; however, attack duration and frequency was stable between individuals. This large prospective study is the first ever completed in subjects with EA1. We document the natural history of the disorder over 2\u00a0years. These data will enable the development of outcome measures for clinical trials of treatment.<\/jats:p>","DOI":"10.1007\/s12311-021-01360-6","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T02:02:46Z","timestamp":1654221766000},"page":"578-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Episodic Ataxia Type 1: Natural History and Effect on Quality of Life"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0010-6169","authenticated-orcid":false,"given":"Tracey D.","family":"Graves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Griggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian N.","family":"Bundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna C.","family":"Jen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Baloh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the CINCH Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna J.","family":"Jen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony A.","family":"Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika F.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Herr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Salajegheh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araya","family":"Puwanant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Rajakalendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon-Hee","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Krischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Herbelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Roe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Ruhlig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Richesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"issue":"2","key":"1360_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ng1094-136","volume":"8","author":"DL Browne","year":"1994","unstructured":"Browne DL, et al. Episodic ataxia\/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet. 1994;8(2):136\u201340.","journal-title":"Nat Genet"},{"issue":"Pt 10","key":"1360_CR2","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/brain\/awm126","volume":"130","author":"JC Jen","year":"2007","unstructured":"Jen JC, et al. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain. 2007;130(Pt 10):2484\u201393.","journal-title":"Brain"},{"issue":"Pt 4","key":"1360_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/brain\/awu012","volume":"137","author":"TD Graves","year":"2014","unstructured":"Graves TD, et al. Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation. Brain. 2014;137(Pt 4):1009\u201318.","journal-title":"Brain"},{"issue":"11","key":"1360_CR4","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717\u201320.","journal-title":"Neurology"},{"issue":"6","key":"1360_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"11","key":"1360_CR6","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","volume":"14","author":"H Jacobi","year":"2015","unstructured":"Jacobi H, et al. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol. 2015;14(11):1101\u20138.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1360_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mds.23879","volume":"27","author":"C Marelli","year":"2012","unstructured":"Marelli C, et al. Annual change in Friedreich\u2019s ataxia evaluated by the Scale for the Assessment and Rating of Ataxia (SARA) is independent of disease severity. Mov Disord. 2012;27(1):135\u20138.","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"1360_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2008.05.009","volume":"272","author":"E Epstein","year":"2008","unstructured":"Epstein E, et al. Health related quality of life measures in Friedreich Ataxia. J Neurol Sci. 2008;272(1\u20132):123\u20138.","journal-title":"J Neurol Sci"},{"issue":"6","key":"1360_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jocn.2013.08.030","volume":"21","author":"X Wu","year":"2014","unstructured":"Wu X, et al. Sex differences in health-related quality of life among adult stroke patients in Northeastern China. J Clin Neurosci. 2014;21(6):957\u201361.","journal-title":"J Clin Neurosci"},{"key":"1360_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.parkreldis.2018.01.006","volume":"49","author":"D Zielonka","year":"2018","unstructured":"Zielonka D, et al. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington\u2019s disease. Parkinsonism Relat Disord. 2018;49:42\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"1360_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nrl.2015.09.002","volume":"32","author":"CR S\u00e1nchez-L\u00f3pez","year":"2017","unstructured":"S\u00e1nchez-L\u00f3pez CR, et al. Health-related quality of life in patients with spinocerebellar ataxia. Neurologia. 2017;32(3):143\u201351.","journal-title":"Neurologia"},{"issue":"3","key":"1360_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1471-6712.2008.00633.x","volume":"23","author":"M Krokavcova","year":"2009","unstructured":"Krokavcova M, et al. Perceived health status as measured by the SF-36 in patients with multiple sclerosis: a review. Scand J Caring Sci. 2009;23(3):529\u201338.","journal-title":"Scand J Caring Sci"},{"issue":"4","key":"1360_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/009286150904300411","volume":"43","author":"A Zweben","year":"2009","unstructured":"Zweben A, Fucito LM, O\u2019Malley SS. Effective Strategies for Maintaining Research Participation in Clinical Trials. Drug Inf J. 2009;43(4):459\u201367.","journal-title":"Drug Inf J"},{"issue":"Pt 7","key":"1360_CR14","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1093\/brain\/awt133","volume":"136","author":"JR Trivedi","year":"2013","unstructured":"Trivedi JR, et al. Non-dystrophic myotonia: prospective study of objective and patient reported outcomes. Brain. 2013;136(Pt 7):2189\u2013200.","journal-title":"Brain"},{"issue":"1","key":"1360_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/mus.22007","volume":"44","author":"JM Statland","year":"2011","unstructured":"Statland JM, et al. An interactive voice response diary for patients with non-dystrophic myotonia. Muscle Nerve. 2011;44(1):30\u20135.","journal-title":"Muscle Nerve"},{"issue":"13","key":"1360_CR16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/jama.2012.12607","volume":"308","author":"JM Statland","year":"2012","unstructured":"Statland JM, et al. Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial. JAMA. 2012;308(13):1357\u201365.","journal-title":"JAMA"},{"key":"1360_CR17","doi-asserted-by":"crossref","unstructured":"Brueton VC, et al. Strategies to improve retention in randomised trials: a Cochrane systematic review and meta-analysis. BMJ Open. 2014;4(2):e003821.","DOI":"10.1136\/bmjopen-2013-003821"}],"updated-by":[{"DOI":"10.1007\/s12311-022-01450-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000}}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-021-01360-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-021-01360-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-021-01360-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T05:41:06Z","timestamp":1687930866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-021-01360-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1007\/s12311-021-01360-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12311-022-01450-z","asserted-by":"object"}]},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"14 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12311-022-01450-z","URL":"https:\/\/doi.org\/10.1007\/s12311-022-01450-z","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 The authors have no relevant financial or non-financial interests to disclose.\u2022 The authors have no conflicts of interest to declare that are relevant to the content of this article.\u2022 All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committees of the contributing centres. Written informed consent was obtained from study participants. Oversight for protocol consistency was provided by the data management and coordinating centre, which also performed periodic audits.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}